HEPLER, DOUGLAS,DEMPSEY, GAIL L.,JOHNSON, ROLAND,KELLY, MICHAEL,DANIEL, MICHAEL,PAULSEN, NEIL E.,CLAYTON, BERT
申请号：
CA3072335
公开号：
CA3072335A1
申请日:
2018.08.09
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
